Kamet Consulting Group
We don't advise on complex changes. We execute them.
M&A integrations, tech transfers, regulatory strategy, QMS buildouts — we plan, build teams, and deliver outcomes across every function and every market.
Talk to Us17+
Years in Life Sciences
$100B+
In Deals Supported
80+
Countries Across Engagements
4
Sectors: Pharma, Medtech, Digital Health, Consumer Health
The Problems We Solve
Leaders don't need generic consultants. They need someone who's done this before.
01
Multi-country lifecycle changes
Tech transfers, CMC changes, and submissions across dozens of countries — where regulatory, supply chain, and commercial move together.
02
M&A, divestitures & spin-offs
MAH transfers, license transfers, site consolidations, and rebranding — coordinated across every function and market.
03
Regulatory & quality under pressure
Submission backlogs, QMS buildouts, MDR/IVDR compliance, PV transfers — when you need execution, not assessment.
Our Capabilities
What we do — in the language your teams actually use.
01
M&A, Divestitures & Spin-Offs
Entity changes, MAH transfers, license transfers, site consolidations, and rebranding across global portfolios.
02
Tech Transfers & CMC Changes
Post-approval regulatory changes across every market when you move manufacturing, switch CDMOs, or change API sources.
03
Regulatory Strategy & Operations
Submission strategies, pathway selection, lifecycle management, and process optimization from startups to top-20 pharma.
What Our Clients Say
Trusted by teams navigating the most complex changes in life sciences.
“
Kamet helped us map and standardize our end-to-end submission process with a level of rigor and practicality we could implement immediately. Their training and change-management approach drove real adoption across teams.
Global Regulatory Operations
Top Biopharma
Submission process standardization · Global regulatory operations
“
Kamet brought structure and calm to a complex global rebranding program, translating uncertainty into a clear execution plan across markets. They anticipated regulatory risks early and kept the program moving with disciplined governance.
Sr. Director, Global Regulatory Affairs
Medical Device
Global rebranding · 100+ countries · Post-merger execution
Trusted Across Life Sciences
Wound Care Leader
Diabetes Care Company
Cystic Fibrosis Leader
IVD Manufacturer
AI Cancer Screening Startup
Industrial & PSD Segment Leader
Top Consumer Health Company
Dealing with a complex change?
M&A integration, tech transfer, regulatory strategy, QMS buildout, or post-merger rebranding — we've done it before.
Let's Talk